What if I had invested $1,000 in AbbVie in 2017?

$1,000 in AbbVie in 2017

$1,000 put into AbbVie (ABBV) on January 3, 2017, its first trading day of 2017 in our data, was worth $5,988 on September 23, 2026, with dividends counted to the end of 2024. Over the same days to July 31, 2026, $1,000 in the whole US stock market became $3,826.

$1,000 became$5,988by September 23, 2026

Total return+498.8%dividends counted to 2024

A year, on average+20.2%over 9.7 years

The whole US market$3,826same days to July 31, 2026, dividends counted; ABBV by then: $5,669

The S&P 500 index$3,413price only, no dividends

Bought at the close on January 3, 2017, dividends put back in, no costs and no tax. Dividends are counted to the end of 2024; from 2025 on our prices are adjusted for splits only, so dividends paid since then are left out. The stock figure counts dividends; the S&P 500 index figure does not, so compare the stock with the whole-market figure. The market figure is the Fama-French US market return (Kenneth R. French data library), which runs to July 31, 2026. Our stock prices run to September 23, 2026.

Another stock, another year

AbbVie in: 2013 · 2014 · 2015 · 2016 · 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Also in 2017

Nvidia · $1,000 became $89,738
Apple Inc. · $1,000 became $12,533
Microsoft · $1,000 became $8,827
Amazon · $1,000 became $6,615
Alphabet Inc. (Class A) · $1,000 became $8,393
Avago Technologies · $1,000 became $25,067
Alphabet Inc. - Class C Capital Stock · $1,000 became $8,553
Meta Platforms · $1,000 became $6,392

Ask the Lab what the market did next

History, not advice. How these numbers are made.